A promising molecule can survive a bad metaphor. A young biotech usually cannot. SCIENT built its business around the awkward, consequential work of making complicated science understandable before the next investor meeting, clinical milestone, or corporate turning point.
Gia Vecchio built a PR firm around a contrarian idea: the best restaurant story may not be a restaurant story at all. Eight years later, Foxglove has turned that instinct into a multi-city, self-funded agency with a taste for moving hospitality into the wider culture.